|
![]() |
|
|
Ciprofloxacin
drug data and news
Ciprofloxacin drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Ciprofloxacin | ||
| Brand Names/Synonyms | Bacquinor; Baycip; Bernoflox; CIPROFLOXACIN HCL; Ciflox; Cifloxin; Ciloxan; Ciprinol; Cipro; Cipro I.V.; Cipro Xl; Cipro Xr; Ciprobay; Ciprocinol; Ciprodar; Ciprofloxacin; Ciprofloxacin Base; Ciprofloxacin Dihydrochloride; Ciprofloxacin Hydrochloride; Ciprofloxacin Monohydrochloride; Ciprofloxacina; Cipromycin; Ciproquinol; Ciproxan; Ciproxin; Flociprin; Floxin; Floxin Otic; Floxin in Dextrose 5%; Ocuflox; Ofloxacin; Proquin Xr; Septicide; Velomonit | ||
| Indication | For the treatment of Bacterial infection of Respiratory tract, UTI, Uncomplicated Cystitis in females, GI, Chronic Bacterial Prostatitis, CNS, Immuno compromised patients, Skin, Bone and Joint Infections, Uncomplicated cervical and urethral gonorrhea | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Ciprofloxacin, a broad-spectrum antiinfective agent of the fluoroquinolone class, is used to treat gram-negative infections, sexually transmitted diseases, mycobacterial infections, corneal ulcers, and bacterial conjunctivitis. | ||
| Mechanism Of Action | Ciprofloxacin has in vitro activity against a wide range of gram-negative and gram-positive organisms. Ciprofloxacin inhibits bacterial DNA gyrase, an enzyme responsible for counteracting excessive supercoiling of DNA during replication or transcription. The mechanism of action of quinolones, including ciprofloxacin, is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, organisms resistant to these drugs may be susceptible to ciprofloxacin. There is no known cross-resistance between ciprofloxacin and other classes of antimicrobials. | ||
| Ciprofloxacin News (When available) |
Testosterone And Manhood 07 Mar 2006 Team SA on a high after Oscar win 07 Mar 2006 Sex Chromosome Genes Influence Aggression Andmaternal Behavior ... 07 Mar 2006 Oscient Pharmaceuticals Reports Financial Results for Fourth ... 07 Mar 2006 Sports Nutrition 07 Mar 2006 Hunting's one of safest sports, far safer than basketball, Rev. ... 07 Mar 2006 Moms make lousy dads 07 Mar 2006 Not Wanting to Be Left Out, Men Find Their Own 'Pause' 07 Mar 2006 New shows take wing — but will they fly? 07 Mar 2006 A woman's guide to success in the Kremlin 07 Mar 2006 Iran: More Jaw and Less War 07 Mar 2006 Germans bid to purge themselves from their doping past 07 Mar 2006 Can you choose your baby's sex? 07 Mar 2006 Hawksley Workman (Darren Calabrese/cns) 07 Mar 2006 Women in Sport promotion set to push limits 07 Mar 2006 What's on tonight? Monday 07 Mar 2006 Gospel of impotence 07 Mar 2006 Hair Today - Gone Tomorrow? 07 Mar 2006 A Sensual Tango of the Dances 07 Mar 2006 VW's nasty new spokesdemon. 07 Mar 2006 On the road: I Keano, Up on Roof, The Long and the Short and the ... 07 Mar 2006 Testosterone Deprivation Doesn't Stop Prostate Cancer: Study Feb 27, 2006 Lifestyle, Health Related to a Good Sex Life as Men Age, Says the ... Mar 6, 2006 School remains testosterone-free zone Feb 24, 2006 Health Canada Issues Warning on Methyl-1-Testosterone Feb 23, 2006 The Sub-Fertile Stallion Mar 6, 2006 Theology and testosterone Feb 5, 2006 Hollywood testosterone king Michael Bay has been charged with ... Feb 14, 2006 CROI: Disappointment for glitazones, metformin and testosterone ... Feb 10, 2006 Testosterone influences sexual behaviour Feb 9, 2006 Phil Parker: Testosterone is on parade today Feb 15, 2006 Testosterone Replacement in Older Men and Atherosclerosis ... Feb 13, 2006 Encouraging results for Zonagen testosterone drug Feb 6, 2006 Society must find more testosterone Feb 5, 2006 Testosterone proves a fertile area for Ardana Feb 1, 2006 Watson wins approval for generic testosterone product Feb 1, 2006 Following in Darwin’s footprints: Hau unlocks secrets of ... Feb 27, 2006 COMPLETE BREAKDOWN OF WWE WELLNESS PROGRAM Feb 27, 2006 VIVUS Announces Grant of Key Patent for MDTS(R) Delivery System Mar 1, 2006 | ||
| Dosage Forms | LIQUID; OINTMENT; SOLUTION; SUSPENSION; TABLET; TABLET (COMBINED RELEASE); TABLET (EXTENDED-RELEASE) | ||
| Drug_Category | Anti-Infectives; Quinolones; ATC:J01MA02; ATC:S01AX13; ATC:S03AA07 | ||
| Absorption | 70-80% | ||
| Interactions |
-->Interactions for Ciprofloxacin: Caffeine Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life. Cyclosporine Some quinolones, including ciprofloxacin, have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly. Glyburide The concomitant administration of ciprofloxacin with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia. Histamine H2-receptor antagonists Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of ciprofloxacin. Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate. This might increase the risk of methotrexate toxic reactions. Therefore, patients under methotrexate therapy should be carefully monitored when concomitant ciprofloxacin therapy is indicated. Multivalent Cation-Containing Products Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired. Proquin XR should be administered at least 4 hours before or 2 hours after these products. This time window is different than for other oral formulations of ciprofloxacin, which are usually administered 2 hours before or 6 hours after antacids. Non-steroidal anti-inflammatory drugs (but not aspirin) These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies. Omeprazole The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion. Omeprazole should be taken as directed and Proquin XR should be taken with a main meal of the day, preferably the evening meal.. Phenytoin Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant ciprofloxacin. Probenecid Probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum. Theophylline As with some other quinolones, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life. This may result in increased risk of theophylline-related adverse reactions. If concomitant use cannot be avoided, serum levels of theophylline should be monitored and dosage adjustments made as appropriate. Warfarin Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives. When these products are administered concomitantly, prothrombin time or other suitable coagulation tests should be monitored. | ||
| Toxicity | reversible renal toxicity, hypoactivity and cyanosis | ||
| Organisms Affected | Not Available | ||
| Chemical IUPAC Name | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline-3-carboxylicacid | ||
| Chemical Formula | C17H18FN3O3 | ||
| Molecular Weight | 331.342 g/mol | ||
| Smiles String | C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O | ||
| Melting Point | 318-320°C | ||
| Water Solubility | 1.1 mg/L | ||
| State | Solid | ||
| LogP/Hphobicity | 1.335 | ||
| Isoelectric Point | Not Available | ||
| Biotransformation | hepatic | ||
| Half Life | 4 hours | ||
| Protein Binding [%] | 20 to 40% | ||
| RxList Link | RXlist | ||
| Sponsored links | |||
| Drug Reference |
http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/cip1082.shtml http://www.drugs.com/cons/Ciprofloxacin.html http://www.rxlist.com/cgi/generic/cipro.htm | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00424 | ||
| CAS Registry Number | 85721-33-1 | ||
| KEGG Compound ID | C05349 | ||
| PubChem ID | SID:192835 | ||
| PharmGKB ID | PA449009 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | 2248439 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |